KLOW Blend 50mg — Vial Spec, Reconstitution Math & COA

Overview of the KLOW Blend 50mg Format & Laboratory Availability

The KLOW Blend 50mg format represents a total combined lyophilized peptide mass of 50 milligrams, incorporating four well-characterized research peptides: BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu (Copper Tripeptide-1), and KPV (Lysine-Proline-Valine). In laboratory settings, this specific mass configuration is traditionally selected by research teams conducting multi-plate tissue culture assays, cell migration assays, or microfluidic gradient studies requiring higher working concentrations without frequent vial changes.

It is important to note that PX1 Research currently supplies this precise multi-target formulation in our flagship KLOW Blend 80mg format to maximize volumetric efficiency and offer superior cost-per-milligram economics for high-throughput screening environments. However, because legacy laboratory protocols and published literature frequently reference the 50mg total mass configuration, this document provides the exact reconstitution mathematics, volumetric conversions, and handling protocols necessary to adapt 50mg calculations to current laboratory workflows.

Molecular Profiles and Preclinical Mechanisms

Each constituent within the KLOW formulation target distinct cellular pathways involved in structural integrity and inflammatory regulation. In vitro data indicate that BPC-157 modulates vascular endothelial growth factor receptor 2 (VEGFR2) expression, facilitating accelerated endothelial cell tube formation and angiogenesis in hypoxic cell culture models.

Simultaneously, TB-500 functions primarily through actin sequestration. Preclinical studies suggest that by binding monomeric G-actin, TB-500 promotes cell motility, dermal fibroblast migration, and tissue remodeling following cellular micro-injury. Complementing these mechanisms, GHK-Cu acts as a signal peptide that upregulates gene expression for collagen, elastin, and glycosaminoglycans while modulating matrix metalloproteinases (MMPs). Finally, KPV, a tripeptide derived from alpha-MSH, acts through nuclear factor kappa B (NF-κB) inhibition to suppress pro-inflammatory cytokine expression. Together, these four research compounds allow investigators to evaluate multi-target responses in cellular repair models.

Exact Reconstitution Mathematics for a 50mg Lyophilized Mass

Reconstituting a total peptide mass of 50mg (50,000 micrograms) requires accurate micro-pipetting to achieve target stock concentrations. Depending on assay parameters, researchers typically utilize Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4). Below are the volumetric metrics for common diluent volumes added to a 50mg lyophilized cake:

1.0 mL Diluent Addition: Yields a final concentration of 50.0 mg/mL (50.0 µg/µL). This high-density stock solution is ideal for micro-aliquoting into master stock vials to minimize total liquid volume during sub-zero storage. 2.0 mL Diluent Addition: Yields a final concentration of 25.0 mg/mL (25.0 µg/µL). This concentration balances pipetting ease with moderate volumetric displacement in culture media. 3.0 mL Diluent Addition: Yields a final concentration of 16.67 mg/mL (16.67 µg/µL). This standard dilution format allows for precise volumetric transfers when working with multi-well assay plates.

To quickly recalculate concentrations for custom diluent volumes or to adjust calculations for our standard 80mg format, researchers can utilize the PX1 Research reconstitution calculator tool.

Quantitative Aliquoting, Dilution Protocols, and Micro-Pipetting

To preserve peptide integrity and prevent concentration gradients caused by incomplete dissolution, reconstitution protocols must be executed with strict attention to laboratory procedure. Diluent should be introduced down the glass wall of the vial rather than sprayed directly onto the lyophilized cake. Allow the vial to sit at room temperature (20°C–22°C) for 5 to 10 minutes, followed by gentle side-to-side swirling. Vortexing should be strictly avoided, as high-shear mechanical agitation can induce peptide denaturation or aggregation.

Once fully reconstituted, the solution should be sub-aliquoted into low-protein-binding microcentrifuge tubes (e.g., polypropylene) to avoid loss of peptide due to wall adsorption. Aliquoting prevents repeated freeze-thaw cycles, which degrade secondary molecular structures. Each aliquot should be sized according to single-assay requirements (e.g., 50 µL to 100 µL) and stored immediately at target temperatures.

Storage Stability and Handling Protocols

Lyophilized KLOW Blend vials are stable at controlled room temperature for short transit periods, but must be stored at -20°C for medium-term preservation or -80°C for long-term repository storage. In its lyophilized state, protected from light and moisture, the complex maintains purity metrics for up to 24 months.

After reconstitution, stock solutions stored at 4°C must be utilized within 14 to 21 days when prepared with bacteriostatic diluents. If prepared in unpreserved sterile saline or PBS for sensitive cell culture applications, reconstituted solutions should be used immediately or stored at -80°C in single-use aliquots. Reconstituted frozen aliquots remain stable for up to 6 months; however, repeated freeze-thaw events must be limited to zero to maintain exact quantitative fidelity across serial experiments.

Analytical Verification: ISO 17025 HPLC/MS and Endotoxin Testing

To ensure reproducible outcomes in preclinical models, PX1 Research subjects every synthesis lot to rigorous third-party analytical verification. High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity, ensuring every component meets or exceeds our strict >99% purity benchmark. Mass Spectrometry (MS) confirms exact molecular weight identity for each of the four linear and cyclic peptide chains within the blend.

Furthermore, because bacterial lipopolysaccharides can alter cell culture behavior and confound inflammatory markers, all lots undergo Chromogenic Recombinant Factor C (rFC) or LAL assay testing to verify endotoxin levels remain below <0.01 EU/mg. Researchers can inspect lot-matched analytical documentation directly on our dedicated COA portal.

Comparative Analysis: Multi-Peptide Blends vs. Standalone Monomers

When evaluating experimental design, investigators must weigh the advantages of multi-component blends against individual monomer isolated testing. Standalone research peptides like BPC-157 or individual TB-500 sequences allow researchers to isolate single signaling pathways without confounding variables. Similarly, studies focused solely on copper-binding transport or melanocortin receptor signaling typically deploy isolated GHK-Cu or KPV formulations.

However, multi-peptide complexes like the KLOW Blend enable simultaneous cross-pathway investigation. In preclinical tissue models, cellular responses often rely on concurrent signals: structural scaffold building (GHK-Cu), actin-driven cell migration (TB-500), microvascular formation (BPC-157), and cytokine attenuation (KPV). Comparing complex mixtures against individual monomer controls allows laboratories to observe potential synergistic dynamic responses that single-agent studies cannot reveal. For non-tissue applications, laboratories often evaluate metabolic or endocrine multi-peptide formulations like the CJC-1295 / Ipamorelin blend under similar comparative matrix designs.

Format Evaluation: 50mg Specification vs. 80mg High-Yield Mass

While standard 50mg protocols remain common in legacy literature, high-throughput laboratories increasingly favor higher-yield mass options. Choosing between a 50mg calculated reference and an available 80mg vial standard comes down to volumetric requirements and assay scale. The 80mg format reduces packaging overhead, minimizes vial-to-vial reconstitution variance across large plate runs, and lowers total handling requirements for high-concentration dosing protocols.

Researchers seeking to explore our full line of multi-target mixtures, single-sequence peptides, and customized research formats can browse the complete catalog via the PX1 Research all peptides directory.

Procurement, Institutional Accounts, and Shipping Logistics

PX1 Research provides fully compliant procurement workflows for academic institutions, contract research organizations (CROs), and private biotechnology facilities. Products are manufactured in USA-based, GMP-compliant facilities operating under ISO 17025 laboratory accreditations. Bulk orders, recurring assay supply arrangements, and institutional invoicing can be managed directly through our dedicated wholesale portal.

All orders placed Monday through Friday before cut-off times are dispatched same-day from our primary distribution hubs located in California and Arizona. Lyophilized peptides are packaged in temperature-controlled, shock-mitigating materials to ensure structural integrity during transit. For deep-dive protocol documentation and published literature summaries, visit our central research hub.